BREAKING NEWS
Medical Marijuana
Reclassified to Schedule III
The DOJ just made the most significant change to federal cannabis policy in over 50 years. Here’s what it actually means.
April 23, 2026
The Order
On Thursday, Acting Attorney General Todd Blanche signed an order immediately reclassifying two categories of marijuana from Schedule I to Schedule III of the Controlled Substances Act:
✅ FDA-approved products containing marijuana
✅ Marijuana products regulated under a state medical cannabis license
That second category is the big one. It means every state-licensed medical dispensary in the country — including all Vibe Cannabis locations in California and Oregon — now operates under a federal classification that formally recognizes cannabis as having accepted medical use.
The order follows President Trump’s December 18, 2025 executive order directing the AG to expedite the move. Four months later, the signature landed.
From the Acting Attorney General
“These actions will enable more targeted, rigorous research into marijuana’s safety and efficacy, expanding patients’ access to treatments and empowering doctors to make better-informed healthcare decisions.”
— Acting Attorney General Todd Blanche, via X
Blanche confirmed the DOJ was “immediately rescheduling FDA-approved marijuana and state-licensed marijuana from Schedule I to Schedule III.” He also announced an expedited administrative hearing beginning June 29, 2026 to consider broader rescheduling of all marijuana — not just state-licensed medical products.
What Actually Changed
|
SCHEDULE I — BEFORE “No currently accepted medical use and a high potential for abuse.” • Same classification as heroin and LSD |
SCHEDULE III — NOW “Moderate to low potential for dependence.” • Accepted medical use recognized |
The $15 Billion Tax Problem — Solved
For cannabis operators, the most immediate financial impact is the end of Internal Revenue Code Section 280E — a 1982 tax provision that blocked businesses selling Schedule I or II substances from deducting ordinary expenses or claiming tax credits.
The numbers are staggering. According to a Whitney Economics analysis released earlier this month:
|
$27B Total federal taxes paid since 2018 |
$15B Excess taxes from 280E alone |
$2.2B Annual cash flow unlocked |
Blanche’s order goes further, noting it “encourages” the Treasury Secretary “to consider providing retrospective relief from Section 280E liability for taxable years in which a state licensee operated under a state medical marijuana license.”
That said, whether retroactive relief actually materializes is still an open question. Current legal guidance suggests 280E relief will likely be prospective — applying to future tax years — rather than generating refunds for the past.
What This Means for California Patients
If you’re a medical cannabis patient in California or Oregon, your day-to-day access at Vibe Cannabis dispensaries doesn’t change overnight. State law has protected your right to purchase and use medical cannabis since California voters passed Proposition 215 in 1996.
What does change is the federal backdrop. The gap between state legality and federal prohibition — the contradiction that created gray areas around employment, housing, banking, and research — just got significantly narrower. Schedule III means the federal government formally recognizes that cannabis has accepted medical use. That’s structural, not symbolic.
Research Unlocked
Schedule I classification made it nearly impossible for universities and hospitals to study cannabis in clinical settings — and made institutions worry such work could jeopardize federal funding. Under Schedule III, those barriers fall. Expect:
| ▸ Easier federal grants for studying cannabinoids in pain, PTSD, and sleep disorders |
| ▸ Universities and hospitals cleared to conduct clinical trials without risking federal funding |
| ▸ Better data on dosing, strain-specific effects, therapeutic applications, and safety profiles |
| ▸ Better science = better products, better dosing guidelines, better medicine for everyone |
New Requirements for State Licensees
Schedule III isn’t just a label change — it comes with new federal compliance obligations:
|
① DEA Registration — State licensees must register as marijuana manufacturers, distributors, or dispensers |
|
② Federal Compliance — Follow rules for disposal, security, and labeling under Schedule III |
|
③ Dual Frameworks — Maintain compliance with both state and federal requirements simultaneously |
The DOJ is establishing an expedited review process for state licensees seeking federal registration. This is uncharted territory — no one has navigated dual state-federal cannabis compliance at this scale before.
What About Banking?
One of the industry’s longest-standing pain points has been access to financial services. Cannabis businesses have been forced to operate largely in cash because most banks won’t touch Schedule I money.
Schedule III doesn’t automatically open full federal banking access. But it dramatically improves the climate and is expected to clear the path for the SAFER Banking Act, which would grant dispensaries access to:
|
💳 Credit card processing |
🏦 Traditional business loans |
📈 Standard financial services |
For operators who’ve been running cash-heavy businesses for years, that shift alone could be transformative.
Industry Reaction
“The rescheduling of cannabis products is a tremendous step forward for the regulated cannabis industry. The implementation helps operators, big and small, by lessening tax burdens, opening up channels for research, and furthering the normalization of a product that benefits millions.”
— Peter Sack, Chicago Atlantic
“We’re talking about billions of dollars in new economic activity, tens of thousands of new jobs — really a wind in the sail for this industry that’s paid a very heavy tax burden for years.”
— Brian Vicente, Founding Partner, Vicente LLP
“The improved cash flow from rescheduling would support reinvestment, strengthen stability, and help build momentum for more consistent standards over time.”
— Wendy Bronfein, Co-Founder & Chief Brand Officer, Curio Wellness
THE COUNTERPOINT
Not everyone is celebrating. Smart Approaches to Marijuana has announced it will take “legal action immediately” against the order. And even within the industry, operators caution that adult-use businesses in recreational-only states still face Schedule I uncertainty until the June 29 hearing at the earliest. Rescheduling is a first step — not the finish line.
What This Does NOT Do
Headlines will oversimplify this. Here’s the reality:
|
✘ Does not legalize marijuana — not for medical, not for recreational, not under federal law |
|
✘ Recreational cannabis stays Schedule I — only state-licensed medical and FDA products move to III |
|
✘ Does not change state laws — CA’s Prop 64 and OR’s Measure 91 remain the backbone of legal access |
|
✘ Does not release anyone from prison — federal marijuana sentences are not affected |
|
✘ Does not open interstate commerce — cannabis still cannot legally cross state lines |
This is the most significant federal policy shift on cannabis in half a century. It is not legalization. That distinction matters.
What’s Next: June 29 and Beyond
Today’s order may be the beginning of something bigger. The DOJ ordered an expedited administrative hearing beginning June 29, 2026 to evaluate broader rescheduling of all marijuana — including adult-use. That hearing will provide what the DOJ calls “a timely and legally compliant pathway to evaluate broader changes to marijuana’s status under federal law.”
Timeline to Watch
| Dec 18, 2025 | Trump signs executive order directing rescheduling |
| Apr 23, 2026 | AG Blanche signs order — state-licensed medical moves to Schedule III |
| Jun 29, 2026 | Expedited hearing begins for broader rescheduling of ALL marijuana |
If the June hearing leads to broader rescheduling, the ripple effects would touch every corner of the industry — from adult-use markets to banking to interstate commerce. We’ll be covering it as it develops.
Expect legal challenges. Smart Approaches to Marijuana, a national anti-legalization organization, has already announced it will take “legal action immediately” to block the order. How courts respond could shape the speed and scope of implementation.
What This Means for Vibe Cannabis
As a vertically integrated, publicly held cannabis company with dispensaries across California and Oregon, Vibe Cannabis has operated in the gap between state and federal law since day one. Today’s rescheduling validates what we’ve been building toward — but we’re clear-eyed about the work ahead.
280E relief means healthier margins and more investment in our people, our product, and our communities. Research unlocks mean better science behind what we carry. The June hearing could open doors we’ve been knocking on for years. And the new DEA registration requirements mean compliance work that we’re already preparing for.
In the meantime, nothing changes at your local Vibe — same quality flower, same knowledgeable budtenders, same California vibes. Stop by any of our eight locations in Sacramento, Stockton, Redding, Ukiah, Moreno Valley, and Portland.
Stay Informed. Stay Lifted.
The cannabis landscape is shifting fast. Visit your local Vibe Cannabis dispensary or browse our menu online.
Must be 21+ to purchase. Consume responsibly. This article is for informational purposes only and does not constitute legal or tax advice.
